Prevention of Shivering During Therapeutic Temperature Modulation: The Columbia Anti-Shivering Protocol
H. Alex Choi(Texas Medical Center), Neeraj Badjatia(University of Maryland, Baltimore), Christine Lesch(NewYork–Presbyterian Hospital), Amanda Carpenter(The Neurological Institute), Mary Presciutti(Columbia University Irving Medical Center), Emily Gilmore(The Neurological Institute), J. Michael Schmidt(University of Southern California), Luis Fernández‐Salazar(Hospital Clínico Universitario de Valladolid), Sang‐Bae Ko(Seoul National University), Kiwon Lee(The Neurological Institute), Jan Claassen(Columbia University), Rishi Malhotra(Unknown), Stephan A. Mayer(Westchester Medical Center)
Cited by 191
Related Papers
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|The Lancet|2020|2.3k
Guidelines for the Evaluation and Management of Status Epilepticus
|Neurocritical Care|2012|1.6k
A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC)
|Intensive Care Medicine|2019|623
Defining Vasospasm After Subarachnoid Hemorrhage
|Stroke|2009|592